No Data
CHINARES PHARMA (03320.HK) has signed a strategic cooperation agreement with Banks for 2025.
On December 31, Gelonghui reported that CHINARES PHARMA (03320.HK) announced that on December 31, 2024, the company entered into a 2025 strategic cooperation agreement with CHINARES Banks and a 2025 strategic cooperation agreement with CHINARES REITs, effective from January 1, 2025, and ending on December 31, 2027.
CR MEDICAL (01515) has signed a business Travel Services framework agreement with CR Digital Technology.
CR MEDICAL (01515) announced that on December 30, 2024, the company entered into an agreement with CR Digital Technology...
CR MEDICAL (01515.HK) has entered into a business travel services agreement with CR Technology.
Gelonghui reported on December 30 that CR MEDICAL (01515.HK) announced that on December 30, 2024, the company entered into a framework agreement for Business Travel Services with CR Digital Technology. According to this, CR Digital Technology Group has agreed to provide several Business Travel Services to the group, with the term starting from January 1, 2025, to December 31, 2027.
China Resources Medical Holdings Insider Lowered Holding By 100% During Last Year
[Brokerage Focus] Tianfeng maintains a 'buy' rating on CR Medical (01515), indicating its leading market size and good growth potential.
Jingu Wealth News | Tianfeng Securities' research report pointed out that CR Medical (01515) achieved revenue of 4.976 billion yuan in the first half of 2024, a decrease of 2.7% year-on-year, with a net income of 0.434 billion yuan, an increase of 9.0% year-on-year. The overall performance meets expectations. The report mentioned that in the first half of 2024, the number of medical consultations in both self-owned hospitals increased. The outpatient and inpatient visits were approximately 5.05 million and 280,000 respectively, with a growth of 3.5% and 3.0% respectively compared to the same period last year. Due to the impact of the two-year medical insurance settlement difference, both outpatient and inpatient revenues have declined, decreasing by 2.0% and 8.8% respectively. The report continued to highlight that CR Medical is a
China Resources Medical Holdings Company Limited (HKG:1515) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable
China Resources Medical Holdings (HKG:1515) Sheds HK$726m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Year
Unlock the Full List
